{"name":"Genesys Capital","permalink":"genesys-capital","crunchbase_url":"http://www.crunchbase.com/financial-organization/genesys-capital","homepage_url":"http://www.genesyscapital.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"416-598-4900","description":"","email_address":"info@genesyscapital.com","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Tue Jul 28 00:22:10 UTC 2009","updated_at":"Wed Sep 30 12:27:36 UTC 2009","overview":"<p>Genesys Capital is focused on building companies in the high-growth sectors of healthcare and biotechnology. Through its expertise and network, Genesys accelerates the development of commercially viable emerging companies that represent promising biotechnology investment opportunities.</p>","image":{"available_sizes":[[[141,41],"assets/images/resized/0006/1284/61284v1-max-150x150.jpg"],[[141,41],"assets/images/resized/0006/1284/61284v1-max-250x250.jpg"],[[141,41],"assets/images/resized/0006/1284/61284v1-max-450x450.jpg"]],"attribution":null},"offices":[{"description":"","address1":"200 Front Street West, Suite 3004, P.O. Box 31","address2":"ON","zip_code":"M5V 3K2","city":"Toronto","state_code":null,"country_code":"CAN","latitude":null,"longitude":null}],"relationships":[],"investments":[{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/allostera-pharma-inc-series-c-154m/","source_description":"Allostera Pharma, Inc.: Series C $15.4M","raised_amount":15400000,"raised_currency_code":"USD","funded_year":2009,"funded_month":7,"funded_day":27,"company":{"name":"Allostera Pharma","permalink":"allostera-pharma","image":{"available_sizes":[[[150,36],"assets/images/resized/0005/4442/54442v1-max-150x150.png"],[[175,42],"assets/images/resized/0005/4442/54442v1-max-250x250.png"],[[175,42],"assets/images/resized/0005/4442/54442v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.tiogapharma.com/press/Tioga%20Feb%202010%20Financing%20PR.pdf","source_description":"Tioga Pharmaceuticals, Inc. Raises $18 Million to Fund Phase 3 Clinical Trial in Irritable Bowel Syndrome","raised_amount":18000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":2,"funded_day":17,"company":{"name":"Tioga Pharmaceuticals","permalink":"tioga-pharmaceuticals","image":{"available_sizes":[[[150,58],"assets/images/resized/0007/7570/77570v1-max-150x150.png"],[[250,97],"assets/images/resized/0007/7570/77570v1-max-250x250.png"],[[252,98],"assets/images/resized/0007/7570/77570v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"","source_description":"Cap Funding Report","raised_amount":1180000,"raised_currency_code":"USD","funded_year":2006,"funded_month":8,"funded_day":18,"company":{"name":"Millenium Biologix","permalink":"millenium-biologix","image":null}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.thefreelibrary.com/StemPath+Inc.+Announces+$1+Million+Private+Financing.-a0142462444","source_description":"StemPath Inc. Announces $1 Million Private Financing.","raised_amount":1000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":2,"funded_day":24,"company":{"name":"StemPath","permalink":"stempath","image":null}}},{"funding_round":{"round_code":"a","source_url":"http://www.fiercebiotech.com/story/naurex-raises-18m-ph2-depression-program/2011-05-11?utm_medium=rss&utm_source=rss","source_description":"Naurex raises $18M for Ph2 depression program","raised_amount":18000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":5,"funded_day":11,"company":{"name":"Naurex","permalink":"naurex","image":{"available_sizes":[[[150,49],"assets/images/resized/0013/4243/134243v1-max-150x150.jpg"],[[240,79],"assets/images/resized/0013/4243/134243v1-max-250x250.jpg"],[[240,79],"assets/images/resized/0013/4243/134243v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.biospace.com/News/functional-neuromodulation-inc-closes-10-4-million/236687/Source=TopBreaking","source_description":"Functional Neuromodulation Inc. Closes $10.4 Million Financing ","raised_amount":10400000,"raised_currency_code":"USD","funded_year":2011,"funded_month":10,"funded_day":17,"company":{"name":"Functional Neuromodulation","permalink":"functional-neuromodulation","image":{"available_sizes":[[[150,35],"assets/images/resized/0015/8664/158664v1-max-150x150.jpg"],[[250,59],"assets/images/resized/0015/8664/158664v1-max-250x250.jpg"],[[450,106],"assets/images/resized/0015/8664/158664v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.tiogapharma.com/press/Tioga%20Series%20B%20PR%20FINAL.pdf","source_description":"Tioga Pharmaceuticals, Inc. Raises $10 Million to Advance Phase 3 Clinical Development of Asimadoline in Irritable Bowel Syndrome","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":4,"funded_day":12,"company":{"name":"Tioga Pharmaceuticals","permalink":"tioga-pharmaceuticals","image":{"available_sizes":[[[150,58],"assets/images/resized/0007/7570/77570v1-max-150x150.png"],[[250,97],"assets/images/resized/0007/7570/77570v1-max-250x250.png"],[[252,98],"assets/images/resized/0007/7570/77570v1-max-450x450.png"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}